CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Feb 25, 16:00
CureVac Research and Development Expense (Quarterly) : 44.70M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioNTech SE | 660.04M |
| Bayer AG | 1.750B |
| MediGene AG | -- |
| InflaRx NV | 7.293M |
| Immatics NV | 55.13M |